ACEI或ARB单药治疗控制不佳的亚洲高血压患者开放性应用氯沙坦氢氯噻嗪联合治疗的有效性.pdf

ACEI或ARB单药治疗控制不佳的亚洲高血压患者
开放性应用氯沙坦/氢氯噻嗪联合治疗的有效性
Effectiveness of open-label losartan/
bination therapy in
Asian patients with hypertension not controlled with
ACE inhibitor or ARB monotherapy
Kee-Sik Kim1, Wei Hu Fan2, Young-Dae Kim3, Wenling Zhu4, Yen Yew Ngau5, Peter Tong6, Byung-Soo Kim7,
Maureen Santos8, Wei-Hsiang Lin9, Peera Buranakitjaroen10, Rachid Massaad11 and Ronald D Smith12,
for the Asia HEAALTH Study Investigators
1Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, Republic of Korea; 2Department of Internal
Medicine, Huashan Hospital, Shanghai, China; 3Department of Internal Medicine, Dong-A University Hospital, Busan, Republic
of Korea; 4Department of Internal Medicine, Peking Union Medical College Hospital, Beijing, China; 5Department of Internal
Medicine, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia; 6Department of Internal Medicine, Prince of Wales Hospital, The
Chinese University of Hong Kong, Hong Kong; 7Department of Internal Medicine, Dae-Dong Hospital, Busan, Republic of Korea;
8Department of Internal Medicine, Cebu Doctors’ University Hospital, Cebu, Philippines; 9Department of Internal Medicine,
Tri-Service General Hospital, Taipei City, Taiwan; 10Department of Internal Medicine, Siriraj Hospital, Mahidol University,
Bangkok, Thailand; 11MSD (Europe) Inc., Brussels, Belgium and 12Merck and Co. Inc., Whitehouse Station, NJ, USA
Correspondence: Dr K-S Kim, Department of Internal Medicine, Daegu Catholic University Medical Center, 3056-6, Daemyung 4
Dong, Namgu Deagu 705–718, Republic of Korea.
Reprinted from Hypertension Research (2009) 32, 520–526
© 2009 by the Japanese Society of Hypertension
All rights reserved. Nature Publishing Group reprint and translate this article on behalf of the Japanese Society of Hyperten-
sion, and authorize Hangzhou MSD Pharmaceutical Co., Ltd. to freely distribute such reprint to medical professionals. No part
of this publication may be repro